Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples